Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
1.
SN Operations Research Forum ; 4(1), 2023.
Article in English | EuropePMC | ID: covidwho-2258408

ABSTRACT

Understanding clinical features and risk factors associated with COVID-19 mortality is needed to early identify critically ill patients, initiate treatments and prevent mortality. A retrospective study on COVID-19 patients referred to a tertiary hospital in Iran between March and November 2020 was conducted. COVID-19-related mortality and its association with clinical features including headache, chest pain, symptoms on computerized tomography (CT), hospitalization, time to infection, history of neurological disorders, having a single or multiple risk factors, fever, myalgia, dizziness, seizure, abdominal pain, nausea, vomiting, diarrhoea and anorexia were investigated. Based on the investigation outcome, decision tree and dimension reduction algorithms were used to identify the aforementioned risk factors. Of the 3008 patients (mean age 59.3 ± 18.7 years, 44% women) with COVID-19, 373 died. There was a significant association between COVID-19 mortality and old age, headache, chest pain, low respiratory rate, oxygen saturation < 93%, need for a mechanical ventilator, having symptoms on CT, hospitalization, time to infection, neurological disorders, cardiovascular diseases and having a risk factor or multiple risk factors. In contrast, there was no significant association between mortality and gender, fever, myalgia, dizziness, seizure, abdominal pain, nausea, vomiting, diarrhoea and anorexia. Our results might help identify early symptoms related to COVID-19 and better manage patients according to the extracted decision tree. The proposed ML models identified a number of clinical features and risk factors associated with mortality in COVID-19 patients. These models if implemented in a clinical setting might help to early identify patients needing medical attention and care. However, more studies are needed to confirm these findings.

2.
Inf Fusion ; 90: 364-381, 2023 Feb.
Article in English | MEDLINE | ID: covidwho-2061287

ABSTRACT

The COVID-19 (Coronavirus disease 2019) pandemic has become a major global threat to human health and well-being. Thus, the development of computer-aided detection (CAD) systems that are capable of accurately distinguishing COVID-19 from other diseases using chest computed tomography (CT) and X-ray data is of immediate priority. Such automatic systems are usually based on traditional machine learning or deep learning methods. Differently from most of the existing studies, which used either CT scan or X-ray images in COVID-19-case classification, we present a new, simple but efficient deep learning feature fusion model, called U n c e r t a i n t y F u s e N e t , which is able to classify accurately large datasets of both of these types of images. We argue that the uncertainty of the model's predictions should be taken into account in the learning process, even though most of the existing studies have overlooked it. We quantify the prediction uncertainty in our feature fusion model using effective Ensemble Monte Carlo Dropout (EMCD) technique. A comprehensive simulation study has been conducted to compare the results of our new model to the existing approaches, evaluating the performance of competing models in terms of Precision, Recall, F-Measure, Accuracy and ROC curves. The obtained results prove the efficiency of our model which provided the prediction accuracy of 99.08% and 96.35% for the considered CT scan and X-ray datasets, respectively. Moreover, our U n c e r t a i n t y F u s e N e t model was generally robust to noise and performed well with previously unseen data. The source code of our implementation is freely available at: https://github.com/moloud1987/UncertaintyFuseNet-for-COVID-19-Classification.

3.
Contrast Media Mol Imaging ; 2022: 8733632, 2022.
Article in English | MEDLINE | ID: covidwho-1932851

ABSTRACT

Myocarditis is heart muscle inflammation that is becoming more prevalent these days, especially with the prevalence of COVID-19. Noninvasive imaging cardiac magnetic resonance (CMR) can be used to diagnose myocarditis, but the interpretation is time-consuming and requires expert physicians. Computer-aided diagnostic systems can facilitate the automatic screening of CMR images for triage. This paper presents an automatic model for myocarditis classification based on a deep reinforcement learning approach called as reinforcement learning-based myocarditis diagnosis combined with population-based algorithm (RLMD-PA) that we evaluated using the Z-Alizadeh Sani myocarditis dataset of CMR images prospectively acquired at Omid Hospital, Tehran. This model addresses the imbalanced classification problem inherent to the CMR dataset and formulates the classification problem as a sequential decision-making process. The policy of architecture is based on convolutional neural network (CNN). To implement this model, we first apply the artificial bee colony (ABC) algorithm to obtain initial values for RLMD-PA weights. Next, the agent receives a sample at each step and classifies it. For each classification act, the agent gets a reward from the environment in which the reward of the minority class is greater than the reward of the majority class. Eventually, the agent finds an optimal policy under the guidance of a particular reward function and a helpful learning environment. Experimental results based on standard performance metrics show that RLMD-PA has achieved high accuracy for myocarditis classification, indicating that the proposed model is suitable for myocarditis diagnosis.


Subject(s)
COVID-19 , Myocarditis , Algorithms , COVID-19/diagnostic imaging , Humans , Iran , Myocarditis/diagnostic imaging , Myocarditis/pathology , Neural Networks, Computer
4.
Expert Syst Appl ; 201: 116942, 2022 Sep 01.
Article in English | MEDLINE | ID: covidwho-1763726

ABSTRACT

Radiological methodologies, such as chest x-rays and CT, are widely employed to help diagnose and monitor COVID-19 disease. COVID-19 displays certain radiological patterns easily detectable by X-rays of the chest. Therefore, radiologists can investigate these patterns for detecting coronavirus disease. However, this task is time-consuming and needs lots of trial and error. One of the main solutions to resolve this issue is to apply intelligent techniques such as deep learning (DL) models to automatically analyze the chest X-rays. Nevertheless, fine-tuning of architecture and hyperparameters of DL models is a complex and time-consuming procedure. In this paper, we propose an effective method to detect COVID-19 disease by applying convolutional neural network (CNN) to the chest X-ray images. To improve the accuracy of the proposed method, the last Softmax CNN layer is replaced with a K -nearest neighbors (KNN) classifier which takes into account the agreement of the neighborhood labeling. Moreover, we develop a novel evolutionary algorithm by improving the basic version of competitive swarm optimizer. To this end, three powerful evolutionary operators: Cauchy Mutation (CM), Evolutionary Boundary Constraint Handling (EBCH), and tent chaotic map are incorporated into the search process of the proposed evolutionary algorithm to speed up its convergence and make an excellent balance between exploration and exploitation phases. Then, the proposed evolutionary algorithm is used to automatically achieve the optimal values of CNN's hyperparameters leading to a significant improvement in the classification accuracy of the proposed method. Comprehensive comparative results reveal that compared with current models in the literature, the proposed method performs significantly more efficient.

5.
Sci Rep ; 12(1): 815, 2022 01 17.
Article in English | MEDLINE | ID: covidwho-1629950

ABSTRACT

Deep neural networks (DNNs) have been widely applied for detecting COVID-19 in medical images. Existing studies mainly apply transfer learning and other data representation strategies to generate accurate point estimates. The generalization power of these networks is always questionable due to being developed using small datasets and failing to report their predictive confidence. Quantifying uncertainties associated with DNN predictions is a prerequisite for their trusted deployment in medical settings. Here we apply and evaluate three uncertainty quantification techniques for COVID-19 detection using chest X-Ray (CXR) images. The novel concept of uncertainty confusion matrix is proposed and new performance metrics for the objective evaluation of uncertainty estimates are introduced. Through comprehensive experiments, it is shown that networks pertained on CXR images outperform networks pretrained on natural image datasets such as ImageNet. Qualitatively and quantitatively evaluations also reveal that the predictive uncertainty estimates are statistically higher for erroneous predictions than correct predictions. Accordingly, uncertainty quantification methods are capable of flagging risky predictions with high uncertainty estimates. We also observe that ensemble methods more reliably capture uncertainties during the inference. DNN-based solutions for COVID-19 detection have been mainly proposed without any principled mechanism for risk mitigation. Previous studies have mainly focused on on generating single-valued predictions using pretrained DNNs. In this paper, we comprehensively apply and comparatively evaluate three uncertainty quantification techniques for COVID-19 detection using chest X-Ray images. The novel concept of uncertainty confusion matrix is proposed and new performance metrics for the objective evaluation of uncertainty estimates are introduced for the first time. Using these new uncertainty performance metrics, we quantitatively demonstrate when we could trust DNN predictions for COVID-19 detection from chest X-rays. It is important to note the proposed novel uncertainty evaluation metrics are generic and could be applied for evaluation of probabilistic forecasts in all classification problems.


Subject(s)
COVID-19/diagnostic imaging , Deep Learning , Thorax/diagnostic imaging , Humans
6.
Immun Inflamm Dis ; 10(3): e561, 2022 03.
Article in English | MEDLINE | ID: covidwho-1629670

ABSTRACT

INTRODUCTION: To reduce mortality in hospitalized patients with COVID-19 and cardiovascular disease (CVD), it is necessary to understand the relationship between patient's symptoms, risk factors, and comorbidities with their mortality rate. To the best of our knowledge, this paper is the first which take into account the determinants like risk factors, symptoms, and comorbidities leading to mortality in CVD patients who are hospitalized with COVID-19. METHODS: This study was conducted on 660 hospitalized patients with CVD and COVID-19 recruited between January 2020 and January 2021 in Iran. All patients were diagnosed with the previous history of CVD like angina, myocardial infarction, heart failure, cardiomyopathy, abnormal heart rhythms, and congenital heart disease before they were hospitalized for COVID-19. We collected data on patient's signs and symptoms, clinical and paraclinical examinations, and any underlying comorbidities. t test was used to determine the significant difference between the two deceased and alive groups. In addition, the relation between pairs of symptoms and pairs of comorbidities has been determined via correlation computation. RESULTS: Our findings suggest that signs and symptoms such as fever, cough, myalgia, chest pain, chills, abdominal pain, nausea, vomiting, diarrhea, and anorexia had no impact on patients' mortality. There was a significant correlation between COVID-19 cardiovascular patients' mortality rate and symptoms such as headache, loss of consciousness (LOC), oxygen saturation less than 93%, and need for mechanical ventilation. CONCLUSIONS: Our results might help physicians identify early symptoms, comorbidities, and risk factors related to mortality in CVD patients hospitalized for COVID-19.


Subject(s)
COVID-19 , Cardiovascular Diseases , Comorbidity , Humans , Risk Factors , SARS-CoV-2
7.
Results Phys ; 27: 104495, 2021 Aug.
Article in English | MEDLINE | ID: covidwho-1525938

ABSTRACT

The first known case of Coronavirus disease 2019 (COVID-19) was identified in December 2019. It has spread worldwide, leading to an ongoing pandemic, imposed restrictions and costs to many countries. Predicting the number of new cases and deaths during this period can be a useful step in predicting the costs and facilities required in the future. The purpose of this study is to predict new cases and deaths rate one, three and seven-day ahead during the next 100 days. The motivation for predicting every n days (instead of just every day) is the investigation of the possibility of computational cost reduction and still achieving reasonable performance. Such a scenario may be encountered in real-time forecasting of time series. Six different deep learning methods are examined on the data adopted from the WHO website. Three methods are LSTM, Convolutional LSTM, and GRU. The bidirectional extension is then considered for each method to forecast the rate of new cases and new deaths in Australia and Iran countries. This study is novel as it carries out a comprehensive evaluation of the aforementioned three deep learning methods and their bidirectional extensions to perform prediction on COVID-19 new cases and new death rate time series. To the best of our knowledge, this is the first time that Bi-GRU and Bi-Conv-LSTM models are used for prediction on COVID-19 new cases and new deaths time series. The evaluation of the methods is presented in the form of graphs and Friedman statistical test. The results show that the bidirectional models have lower errors than other models. A several error evaluation metrics are presented to compare all models, and finally, the superiority of bidirectional methods is determined. This research could be useful for organisations working against COVID-19 and determining their long-term plans.

8.
Comput Biol Med ; 139: 104994, 2021 12.
Article in English | MEDLINE | ID: covidwho-1487670

ABSTRACT

COVID-19 has had a detrimental impact on normal activities, public safety, and the global financial system. To identify the presence of this disease within communities and to commence the management of infected patients early, positive cases should be diagnosed as quickly as possible. New results from X-ray imaging indicate that images provide key information about COVID-19. Advanced deep-learning (DL) models can be applied to X-ray radiological images to accurately diagnose this disease and to mitigate the effects of a shortage of skilled medical personnel in rural areas. However, the performance of DL models strongly depends on the methodology used to design their architectures. Therefore, deep neuroevolution (DNE) techniques are introduced to automatically design DL architectures accurately. In this paper, a new paradigm is proposed for the automated diagnosis of COVID-19 from chest X-ray images using a novel two-stage improved DNE Algorithm. The proposed DNE framework is evaluated on a real-world dataset and the results demonstrate that it provides the highest classification performance in terms of different evaluation metrics.


Subject(s)
COVID-19 , Deep Learning , Algorithms , Humans , Neural Networks, Computer , SARS-CoV-2
9.
Knowledge-Based Systems ; : 107419, 2021.
Article in English | ScienceDirect | ID: covidwho-1364327

ABSTRACT

This paper proposes a new approach to produce classification rules based on evolutionary computation with novel crossover and mutation operators customized for execution on graphics processing unit (GPU). Also, a novel method is presented to define the fitness function, i.e. the function which measures quantitatively the accuracy of the rule. The proposed fitness function is benefited from parallelism due to the parallel execution of data instances. To this end, two novel concepts;coverage matrix and reduction vectors are used and an altered form of the reduction vector is compared with previous works. Our CUDA program performs operations on coverage matrix and reduction vector in parallel. Also these data structures are used for evaluation of fitness function and calculation of genetic operators in parallel. We proposed a vector called average coverage to handle crossover and mutation properly. Our proposed method obtained a maximum accuracy of 99.74% for Hepatitis C Virus (HCV) dataset, 95.73% for Poker dataset, and 100% for Covid-19 dataset. Our speedup is higher than 20% for HCV and Covid19, and 50% for Poker, compared to using single core processors.

10.
Sci Rep ; 11(1): 15343, 2021 07 28.
Article in English | MEDLINE | ID: covidwho-1331392

ABSTRACT

COVID-19 has caused many deaths worldwide. The automation of the diagnosis of this virus is highly desired. Convolutional neural networks (CNNs) have shown outstanding classification performance on image datasets. To date, it appears that COVID computer-aided diagnosis systems based on CNNs and clinical information have not yet been analysed or explored. We propose a novel method, named the CNN-AE, to predict the survival chance of COVID-19 patients using a CNN trained with clinical information. Notably, the required resources to prepare CT images are expensive and limited compared to those required to collect clinical data, such as blood pressure, liver disease, etc. We evaluated our method using a publicly available clinical dataset that we collected. The dataset properties were carefully analysed to extract important features and compute the correlations of features. A data augmentation procedure based on autoencoders (AEs) was proposed to balance the dataset. The experimental results revealed that the average accuracy of the CNN-AE (96.05%) was higher than that of the CNN (92.49%). To demonstrate the generality of our augmentation method, we trained some existing mortality risk prediction methods on our dataset (with and without data augmentation) and compared their performances. We also evaluated our method using another dataset for further generality verification. To show that clinical data can be used for COVID-19 survival chance prediction, the CNN-AE was compared with multiple pre-trained deep models that were tuned based on CT images.


Subject(s)
COVID-19/diagnosis , COVID-19/mortality , Diagnosis, Computer-Assisted/methods , Forecasting/methods , Neural Networks, Computer , Algorithms , Deep Learning , Humans , Probability , SARS-CoV-2/isolation & purification
11.
Appl Soft Comput ; 111: 107675, 2021 Nov.
Article in English | MEDLINE | ID: covidwho-1306863

ABSTRACT

A novel coronavirus (COVID-19) has globally attracted attention as a severe respiratory condition. The epidemic has been first tracked in Wuhan, China, and has progressively been expanded in the entire world. The growing expansion of COVID-19 around the globe has made X-ray images crucial for accelerated diagnostics. Therefore, an effective computerized system must be established as a matter of urgency, to facilitate health care professionals in recognizing X-ray images from COVID-19 patients. In this work, we design a novel artificial intelligent-based automated X-ray image analysis framework based on an ensemble of deep optimized convolutional neural networks (CNNs) in order to distinguish coronavirus patients from non-patients. By developing a modified version of gaining-sharing knowledge (GSK) optimization algorithm using the Opposition-based learning (OBL) and Cauchy mutation operators, the architectures of the deployed deep CNNs are optimized automatically without performing the general trial and error procedures. After obtaining the optimized CNNs, it is also very critical to identify how to decrease the number of ensemble deep CNN classifiers to ensure the classification effectiveness. To this end, a selective ensemble approach is proposed for COVID-19 X-ray based image classification using a deep Q network that combines reinforcement learning (RL) with the optimized CNNs. This approach increases the model performance in particular and therefore decreases the ensemble size of classifiers. The experimental results show that the proposed deep RL optimized ensemble approach has an excellent performance over two popular X-ray image based COVID-19 datasets. Our proposed advanced algorithm can accurately identify the COVID-19 patients from the normal individuals with a significant accuracy of 0.991441, precision of 0.993568, recall (sensitivity) of 0.981445, F-measure of 0.989666 and AUC of 0.990337 for Kaggle dataset as well as an excellent accuracy of 0.987742, precision of 0.984334, recall (sensitivity) of 0.989123, F-measure of 0.984939 and AUC of 0.988466 for Mendely dataset.

12.
J Med Virol ; 93(4): 2307-2320, 2021 04.
Article in English | MEDLINE | ID: covidwho-1227752

ABSTRACT

Preventing communicable diseases requires understanding the spread, epidemiology, clinical features, progression, and prognosis of the disease. Early identification of risk factors and clinical outcomes might help in identifying critically ill patients, providing appropriate treatment, and preventing mortality. We conducted a prospective study in patients with flu-like symptoms referred to the imaging department of a tertiary hospital in Iran between March 3, 2020, and April 8, 2020. Patients with COVID-19 were followed up after two months to check their health condition. The categorical data between groups were analyzed by Fisher's exact test and continuous data by Wilcoxon rank-sum test. Three hundred and nineteen patients (mean age 45.48 ± 18.50 years, 177 women) were enrolled. Fever, dyspnea, weakness, shivering, C-reactive protein, fatigue, dry cough, anorexia, anosmia, ageusia, dizziness, sweating, and age were the most important symptoms of COVID-19 infection. Traveling in the past 3 months, asthma, taking corticosteroids, liver disease, rheumatological disease, cough with sputum, eczema, conjunctivitis, tobacco use, and chest pain did not show any relationship with COVID-19. To the best of our knowledge, a number of factors associated with mortality due to COVID-19 have been investigated for the first time in this study. Our results might be helpful in early prediction and risk reduction of mortality in patients infected with COVID-19.


Subject(s)
COVID-19/mortality , COVID-19/pathology , Adult , COVID-19/diagnosis , COVID-19/therapy , Critical Illness , Disease Progression , Female , Humans , Iran/epidemiology , Male , Middle Aged , Prospective Studies , Risk Factors , SARS-CoV-2/isolation & purification
13.
Biomed Signal Process Control ; 68: 102622, 2021 Jul.
Article in English | MEDLINE | ID: covidwho-1171832

ABSTRACT

The coronavirus (COVID-19) is currently the most common contagious disease which is prevalent all over the world. The main challenge of this disease is the primary diagnosis to prevent secondary infections and its spread from one person to another. Therefore, it is essential to use an automatic diagnosis system along with clinical procedures for the rapid diagnosis of COVID-19 to prevent its spread. Artificial intelligence techniques using computed tomography (CT) images of the lungs and chest radiography have the potential to obtain high diagnostic performance for Covid-19 diagnosis. In this study, a fusion of convolutional neural network (CNN), support vector machine (SVM), and Sobel filter is proposed to detect COVID-19 using X-ray images. A new X-ray image dataset was collected and subjected to high pass filter using a Sobel filter to obtain the edges of the images. Then these images are fed to CNN deep learning model followed by SVM classifier with ten-fold cross validation strategy. This method is designed so that it can learn with not many data. Our results show that the proposed CNN-SVM with Sobel filter (CNN-SVM + Sobel) achieved the highest classification accuracy, sensitivity and specificity of 99.02%, 100% and 95.23%, respectively in automated detection of COVID-19. It showed that using Sobel filter can improve the performance of CNN. Unlike most of the other researches, this method does not use a pre-trained network. We have also validated our developed model using six public databases and obtained the highest performance. Hence, our developed model is ready for clinical application.

14.
IEEE Trans Neural Netw Learn Syst ; 32(4): 1408-1417, 2021 04.
Article in English | MEDLINE | ID: covidwho-1078912

ABSTRACT

The early and reliable detection of COVID-19 infected patients is essential to prevent and limit its outbreak. The PCR tests for COVID-19 detection are not available in many countries, and also, there are genuine concerns about their reliability and performance. Motivated by these shortcomings, this article proposes a deep uncertainty-aware transfer learning framework for COVID-19 detection using medical images. Four popular convolutional neural networks (CNNs), including VGG16, ResNet50, DenseNet121, and InceptionResNetV2, are first applied to extract deep features from chest X-ray and computed tomography (CT) images. Extracted features are then processed by different machine learning and statistical modeling techniques to identify COVID-19 cases. We also calculate and report the epistemic uncertainty of classification results to identify regions where the trained models are not confident about their decisions (out of distribution problem). Comprehensive simulation results for X-ray and CT image data sets indicate that linear support vector machine and neural network models achieve the best results as measured by accuracy, sensitivity, specificity, and area under the receiver operating characteristic (ROC) curve (AUC). Also, it is found that predictive uncertainty estimates are much higher for CT images compared to X-ray images.


Subject(s)
COVID-19 Testing/methods , COVID-19/diagnosis , Image Interpretation, Computer-Assisted/methods , Transfer, Psychology , Uncertainty , Algorithms , COVID-19/diagnostic imaging , Computer Simulation , Deep Learning , Humans , Machine Learning , Neural Networks, Computer , ROC Curve , Radiography, Thoracic , Reproducibility of Results , Sensitivity and Specificity , Support Vector Machine , Thorax/diagnostic imaging , Tomography, X-Ray Computed
SELECTION OF CITATIONS
SEARCH DETAIL